A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.

Clinical trial NCT07283263 · RECRUITING

Trial details

NCT number: NCT07283263
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2025-12-23
Primary completion: 2026-11-17
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.